Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study

OBJECTIVES: To assess long-term golimumab efficacy/safety in patients with active psoriatic arthritis (PsA). METHODS: Adult PsA patients (≥3 swollen, ≥3 tender joints, active psoriasis) were randomly assigned to subcutaneous injections of placebo, golimumab 50 mg or 100 mg every 4 weeks (q4wks) thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanaugh, Arthur, McInnes, Iain B, Mease, Philip J, Krueger, Gerald G, Gladman, Dafna D, van der Heijde, Désirée, Mudivarthy, Surekha, Xu, Weichun, Mack, Michael, Xu, Zhenhua, Beutler, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812864/
https://www.ncbi.nlm.nih.gov/pubmed/23161902
http://dx.doi.org/10.1136/annrheumdis-2012-202035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812864/
https://www.ncbi.nlm.nih.gov/pubmed/23161902
http://dx.doi.org/10.1136/annrheumdis-2012-202035

Ejemplares similares